GIC Private Ltd sold $721.6 million of Medline Inc. (MDLN) common stock in open-market transactions over a seven day window, with the activity dated October 6th, 2026. The selling was reported across five separate Form 4 filings. GIC Private Ltd is classified in the filings under the role of Other, which covers holders that are neither officers nor directors but file because of their ownership position.
Medline Inc. operates in the Surgical & Medical Instruments & Apparatus sector and carries a market capitalization of $47,830,151,168. The last recorded share price in the window was $35.55. The total above counts only Form 4 code S transactions, meaning shares withheld for tax and disposals back to the issuer are excluded from the figure.
Concentration matters as much as size here. The $721.6 million did not come from a crowd of executives trimming positions at the same time. It came from one distinct seller, and that seller is also the largest seller in the window by a wide margin because there is no one else in the table.
The largest seller is GIC Private Ltd, filing in the role of Other. The number of distinct sellers in the window is one. That single-filer pattern is typical of a large institutional holder reducing a position in tranches rather than of broad insider sentiment at the executive level, and the five filings are consistent with a position unwound across multiple trade dates rather than in one block.
Against the same window, the price data on record shows a last price of $35.55 for Medline Inc. Readers sizing the sale against the company should note the market capitalization of $47,830,151,168 for context on how the $721.6 million compares to the total equity value outstanding.
A sale is not advice and it is not a prediction. A sale may be a scheduled 10b5-1 plan entered months earlier, which means the decision to sell could predate the week the shares actually moved. Insiders and large holders sell for reasons that have nothing to do with the company, including portfolio rebalancing, fund redemptions, diversification, tax planning and liquidity needs. This article is a record of what was filed, nothing more.
One further note on method: only open-market sales are counted in the headline figure. Transfers, gifts, shares surrendered to cover tax withholding and disposals to the issuer are left out, so the $721.6 million reflects stock sold into the market rather than every share that left the holder's account.
Figures in this article come from SEC Form 4 filings made via EDGAR and reviewed by InsiderBuying.com, covering the seven day window ending October 6th, 2026.
Track every Form 4 filed at Medline Inc. (MDLN) → insiderbuying.com/companies/MDLN